Browse articles from EyeWorld.org related to the ocular surface. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
EyeWorld spoke with two experts on the topic of when the Ks don’t align—when misalignment is clinically significant, what can be done about it, and how it impacts lens choices.
➤ Study: ocular manifestations of Mpox ➤ ‘World’s first’ spiral IOL designed with artificial intelligence ➤ First-in-human implantation of wireless IOP sensor ➤ Final patient visit for Phase 2 wet AMD treatment trial ➤ Enrollment, dosing complete for Phase 1 AMD, DME therapy ➤ ASCRS news and events
“My eyes are irritated … they weren’t before cataract surgery.” “My vision fluctuates … it goes in and out.” These just a couple of phrases an ophthalmologist might hear when ABMD is missed prior to cataract surgery, causing them to wish they had found and treated it preoperatively.
“The ASCRS Annual Meeting’s glaucoma programming and scientific content … shows me that while we have a long road ahead of us, the creativity, collaboration, and connectedness that exemplify ASCRS will help us light the way,” said Manjool Shah, MD. He shared what to expect in the Glaucoma section of the issue.
➤ FDA approves first treatment targeting Demodex ➤ Phase 1 study compares mechanical dry eye treatment to drop therapy ➤ Topical gene therapy for rare ocular surface condition ➤ Glaucoma drug licensed for commercialization in U.S. ➤ ASCRS news and events
Optimizing ocular conditions prior to surgery is standard for any procedure, but eyes with glaucoma present extra considerations. EyeWorld spoke with two ophthalmologists to get insights on how to prepare eyes with glaucoma for different ocular procedures. They also shared a few intraoperative and postop considerations along the way.
The use of autologous blood eye drops continues to be a point of interest in research and as a potential cost-effective alternative to processed hemoderivatives. A recent study published in the journal Clinical Ophthalmology continues to advance the topic.
While in recent months mask use has been relaxed somewhat as health guidelines are updated to reflect increased vaccination status and declining case numbers, there are situations where mask wear continues. These have been credited with playing a role in saving lives, but they have been associated with some unintended ocular consequences as well.
Underdiagnosed, often neglected, and much more common than clinicians realize is how some physicians describe conjunctivochalasis. This article is a deep dive into the condition, its diagnosis, and management options.